BPS-MR-PAH-201

· Lung Biotechnology PBC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BPS-MR-PAH-201, covering 2019-12-26 to 2019-12-26. Get the full timeline:

Most recent: Clinical Trial Update: An Open-Label Extension of BPS-MR-PAH-201 in Pulmonary Arterial Hypertension (PAH) Patients [Phase 2]